No Potti retractions on the horizon from JAMA, NEJM

With the third retraction of a paper by Anil Potti this weekend, plus details of various investigations dribbling out, we decided to check in with the world’s two leading medical journals about whether they planned to retract the papers of Potti’s they’d published. JAMA published two papers by Potti and colleagues: One, “Gene Expression Signatures, … Continue reading No Potti retractions on the horizon from JAMA, NEJM

Lancet Oncology retracts previously questioned Anil Potti paper

Early in December, as the house of cards that is Anil Potti‘s publication record started to really collapse, we called attention to a paper in The Lancet Oncology that had already been the subject of a correction and Expression of Concern in July of last year. Today, the journal officially retracted the paper, “Validation of … Continue reading Lancet Oncology retracts previously questioned Anil Potti paper

Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

A quick post this Sunday morning to draw your attention to two must-read items for anyone interested in the Anil Potti case or in how one goes about checking data. (A second paper by Potti et al was officially retracted on Friday.) First, a terrific profile of Joyce Shoffner in the Charlotte News & Observer. … Continue reading Update on Anil Potti: A patient in a trial based on retracted research speaks out; Baggerly on how to prevent the next fiasco

Nature Medicine makes it official, retracting Anil Potti paper

  Nature Medicine has retracted a paper that Anil Potti’s co-author, Joseph Nevins, requested be withdrawn in November. This is the second retraction of a paper by Potti, who resigned from his post at Duke in November in the midst of an investigation into scientific misconduct. The first retraction was in the Journal of Clinical … Continue reading Nature Medicine makes it official, retracting Anil Potti paper

More on Anil Potti: Two other papers worth keeping an eye on

It’s fair to say that we haven’t heard the last of Anil Potti, the Duke cancer researcher who resigned last month following revelations that he had faked some of his results. Duke is still investigating the situation, and has also asked the Institute of Medicine to conduct its own study into the case and its … Continue reading More on Anil Potti: Two other papers worth keeping an eye on

Another update on Anil Potti: Co-author asks Nature Medicine to retract paper

Anil Potti, who resigned from his post at Duke today during an investigation into faked results, will likely have another retraction to his credit shortly. According to a Duke statement: Dr. Potti’s collaborator, Joseph Nevins, Ph.D., has initiated a process intended to lead to a retraction request regarding a paper previously published in Nature Medicine.  … Continue reading Another update on Anil Potti: Co-author asks Nature Medicine to retract paper

Duke’s Anil Potti resigns

Duke’s Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have faked several analyses of chemotherapy and cancer, has resigned from the university. The Duke Chronicle reports that Potti …stepped down from his position at Duke’s Institute for Genome Sciences and Policy Friday and took responsibility for the … Continue reading Duke’s Anil Potti resigns

JCO makes it official, retracting paper co-authored by Anil Potti

We have a follow-up to our post two weeks ago about a possible retraction in the case of Anil Potti, the Duke cancer researcher who falsely claimed to be a Rhodes Scholar and may have also faked an analysis of how breast cancer responds to chemotherapy. In that post, we noted that the Raleigh News … Continue reading JCO makes it official, retracting paper co-authored by Anil Potti

A retraction in the Potti case?

In our very first post, we noted the case of Anil Potti, a Duke researcher who posed as a Rhodes Scholar and appears to have invented key statistical analyses in a study of how breast cancer responds to chemotherapy[.The case] has sent ripples of angst through the cancer community. Potti’s antics prompted editors of The … Continue reading A retraction in the Potti case?